Serum eosinophil cationic protein (S-ECP) in a population with low prevalence of atopy

Respiratory Medicine

Volumn 96, Issue 7, 2002, Pages 525-529

  Jogi R ^a,b   Bjorksten B ^c,d   Boman, G ^a,e   Janson, C ^a,d,f  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b TARTU UNIVERSITY CLINICS   (Estonia)

^c KAROLINSKA INSTITUTE   (Sweden)

^d LINKÖPING UNIVERSITY   (Sweden)

^e UPPSALA UNIVERSITY   (Sweden)

^f KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Asthma; Atopy; Bronchial hyperresponsiveness; Epidemiology; S ECP

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; IMMUNOGLOBULIN E; METHACHOLINE;

ADULT; ARTICLE; ATOPY; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; CORRELATION ANALYSIS; EOSINOPHIL; EUROPE; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH SURVEY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INTERVIEW; LEUKOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROVOCATION TEST; QUESTIONNAIRE; RANDOMIZATION; SENSITIZATION; SMOKING; SYMPTOMATOLOGY;

EID: 0036657120     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1053/rmed.2002.1320     Document Type: Article

References (26)

1. National Institute of Health, National Heart, Lung and Blood Institute. Global initiative for asthma. NIH Publication 95-3659, 1995.
2. Janson C, Boman G. Inflammation and lung damage. Eur Resp Monogr 2000; 5: 272-287.
3. 1, basophil counts, and methacholine response. Thorax 1988; 43: 456-461.
4. Annema JT, Sparrow D, O'Connor GT, Rijcken B, Koeter GH, Postma DS, et al. Chronic respiratory symptoms and airway responsiveness to methacholine are associated with eosinophilia in older men: the Normative Aging Study. Eur Respir J 1995; 8: 62-69.
5. Burrows B, Lebowitz MD, Barbee RA, Cline MG. Findings before diagnoses of asthma among the elderly in a longitudinal study of a general population sample. J Allergy Clin Immunol 1991; 88: 870-877.
6. Mensinga TT, Schouten JP, Rijcken B, Weiss ST, Speizer FE, et al. The relationship of eosinophilia and positive skin test reactivity to respiratory symptom prevalence in a community-based population study. J Allergy Clin Immunol 1990; 86: 99-107.
7. Ulrik CS. Eosinophils and pulmonary function: an epidemiologic study of adolescents and young adults. Ann Allergy Asthma Immunol 1998; 80: 487-493.
8. Bousquet J, Corrigan CJ, Verge P. Peripheral blood markers: evaluation of inflammation in asthma. Eur Respir J 1998; 26(Supp):42S-48S.
9. Verge P. Monitoring of asthma inflammation by serum measurements of eosinophil cationic protein (ECP). A new clinical approach to asthma management. Respir Med 1995; 89: 1-2.
10. Dahl R. Monitoring bronchial asthma in the blood. Allergy 1993; 48(Suppl 17): 77-80.
11. Björnsson E, Janson C, Håkansson L, Enander I, Venge P, Boman G. Serum eosinophil cationic protein in relation to bronchial asthma in a young Swedish population. Allergy 1994; 49: 730-736.
12. Björnsson E, Janson C, Håkansson L, Enander I, Venge P, Boman G. Eosinophil peroxidase: a new serum marker of atopy and bronchial hyperresponsiveness. Respir Med 1996; 90: 39-46.
13. Chinn S, Burney P, Jarvis D, Luczynska C. Variation in bronchial responsiveness in the European Community Respiratory Health Survey (ECRHS). Eur Respir J 1997; 10: 2495-2501.
14. Pearce N, Sunyer J, Cheng S, Chinn S, Björkstén B, Burr M, et al. Comparison of asthma prevalence in the ISAAC and the ECRHS. Eur Respir J 2000; 16: 420-426.
15. Anonymous. Worldwide variations in the prevalence of asthma symptoms: the International Study of Asthma and Allergies in Childhood (ISAAC). Eur Respir J 1998; 12: 315-335.
16. Vasar M, Bråbäck L, Julge K, Knutsson A, Riikjärv MA, Björkstén B. Prevalence of bronchial hyperreactivity as determined by several methods among Estonian schoolchildren. Ped Allergy Immunol 1996; 7: 141-146.
17. Burney P, Luczynska C, Chinn S, Jarvis D, Lai E. Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS). Eur Respir J 1996; 9: 687-695.
18. Jõgi R, Janson C. Bronchial hyperresponsiveness in the general population in Tartu, Estonia compared to Uppsala, Sweden. Am J Respir Crit Care Med 2000; 161: A916.
19. Burney PG, Luczynska C, Chinn S, Jarvis D. The European Community Respiratory Health Survey. Eur Respir J 1994; 7: 954-960.
20. Jõgi R, Janson C, Björnsson E, Boman G, Björkstén B. The prevalence of asthmatic respiratory symptoms among adults in Estonian and Swedish university cities. Allergy 1996; 51: 331-336.
21. Jõgi R, Janson C, Björnsson E, Boman G, Björkstén B. Atopy and allergic disorders among adults in Tartu, Estonia compared with Uppsala, Sweden. Clin Exp Allergy 1998; 28: 1072-1080.
22. European Community for Coal and Steel. Standardization of lung function tests. Clin Respir Phys 1983; 19 (Suppl. 5): 22-27.
23. Jensen EJ, Pedersen B, Schmidt E, Verge P, Dahl R. Serum eosinophilic cationic protein and lactoferrin related to smoking history and lung function. Eur Respir J 1994; 7: 927-933.
24. Mensinga TT, Schouten JP, Weiss ST, van der LR. Relationship of skin test reactivity and eosinophilia to level of pulmonary function in a community-based population study. Am Rev Respir Dis 1992; 146: 638-643.
25. Rubira N, Rodrigo MJ, Pena M, Nogueiras C, Cruz MJ, Cadahia A. Blood sample processing effect on eosinophil cationic protein concentration. Ann Allergy Asthma Immunol 1997; 78: 394-398.
26. Janson C, Anto J, Burney P, et al. The European Community Respiratory Health Survey (ECRHS) so far: what are the main results? Eur Respir J 2001; 18: 598-611.